You are here » Home » Companies » Company Overview » Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd.

BSE: 532305 Sector: Health care
NSE: INDSWFTLAB ISIN Code: INE915B01019
BSE 00:00 | 16 Aug 83.90 -9.00
(-9.69%)
OPEN

95.00

HIGH

95.00

LOW

83.65

NSE 00:00 | 16 Aug 84.15 -9.35
(-10.00%)
OPEN

93.15

HIGH

93.15

LOW

84.15

OPEN 95.00
PREVIOUS CLOSE 92.90
VOLUME 30636
52-Week high 110.75
52-Week low 31.45
P/E 20.61
Mkt Cap.(Rs cr) 380
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 95.00
CLOSE 92.90
VOLUME 30636
52-Week high 110.75
52-Week low 31.45
P/E 20.61
Mkt Cap.(Rs cr) 380
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Ind-Swift Laboratories Ltd. (INDSWFTLAB) - Company Information

Ind-Swift Laboratories Ltd

Ind-Swift Laboratories Ltd is a part of the Ind-swift Group and is based at Chandigarh, India. The company manufactures and sells active pharmaceutical ingredients (API). Their product pipeline consists of 25 products, which includes drugs, which include Clarithromycin (Macrolide antibiotic), Atorvastatin (anticholestrol), Fexofenadine (antihistamine), Clopidogrel (anticholestrol), Nitazoxanide (a...> More

COMPANY INFORMATION
Director : Gopal Munjal
Vice Chairman & M.D. : N R Munjal
Chairman : S R Mehta
Director : V R Mehta
Joint Managing Director : Himanshu Jain
Independent Director : J K Kakkar
Company Secretary : Pradeep Verma
Executive Director : Rishav Mehta
Nominee (SBI) : S V Singh
Independent Director : Ashwani Kumar Vig
Independent Director : Prabhat Khurana
Independent Director : S P Sharma
Independent Director : Poonam Maini
Independent Director : Jagvir Singh Ahluwalia
AUDITOR : Avishkar Singhal & Associates/Jain & Associates
IND NAME : Pharmaceuticals - Indian - Bulk Drugs & Formln
HOUSE NAME : Indian Private
Registered office
SCO 850 Shivalik Enclave, NAC Manimajra,Chandigarh,Chandigarh-160101
Ph : 91-0172-5061850/2730920
WEBSITE : http://www.indswiftlabs.com
E-mail : investor@indswiftlabs.com